Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report)’s stock price rose 0.1% on Tuesday . The company traded as high as $19.14 and last traded at $16.91. Approximately 8,151 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 29,562 shares. The stock had previously closed at $16.90.
Invizyne Technologies Stock Performance
The business’s 50-day moving average price is $15.69.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IZTC. Geode Capital Management LLC purchased a new stake in shares of Invizyne Technologies during the 4th quarter worth approximately $277,000. BNP Paribas Financial Markets purchased a new stake in Invizyne Technologies in the fourth quarter worth $35,000. Finally, Citadel Advisors LLC bought a new stake in shares of Invizyne Technologies in the fourth quarter valued at $456,000.
Invizyne Technologies Company Profile
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
See Also
- Five stocks we like better than Invizyne Technologies
- What is Insider Trading? What You Can Learn from Insider Trading
- GitLab: Get In While It’s Down—Big Rebound Ahead
- How to Use the MarketBeat Stock Screener
- Tesla Stock: Finding a Bottom May Take Time
- What is Short Interest? How to Use It
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
